patent foramen ovale closure
The Risk of Paradoxical Embolism (RoPE) Study: Developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke
... PFO closure in patients with CS has not been demonstrated, and remains ...percutaneous closure, especially if many who receive the device have index strokes unrelated to their ...
9
Percutaneous Patent Foramen Ovale Closure versus Medical Therapy in Cryptogenic Stroke: An Update Meta Analysis of Randomized Controlled Trials
... device closure when com- pared to medical therapy in patients with cryptogenic stroke [14] ...device closure becomes ...device closure, it’s important for clinicians to select appropriate ...als, ...
13
A time-series study of percutaneous closure of patent foramen ovale: premature adoption?
... It is likely that some patients treated with PCPFO in England were included in prospective registries and observational studies; therefore contributed to knowl- edge about adverse events and outcomes, although regis- ...
5
Cryptogenic stroke and patent foramen ovale (abridged and translated version)
... The boards of the three participating scientific societies nominated authors to prepare the recommendations. Each of the five key questions was assigned to a team of authors comprising neurologists and cardiologists to ...
10
Long-term follow-up after closure of patent foramen ovale
... far, CLOSURE (Evaluation of the STARFlex septal closure system in patients with a stroke and/or transient is- chaemic attack due to presumed paradoxical embo- lism through a patent foramen ...
6
Left ventricular decompression through a patent foramen ovale in a patient with hypertrophic cardiomyopathy: a case report
... percutaneous closure of ASD is recom- mended as a preferable alternative to surgical repair, since excellent results in terms of efficacy and complications [1] are associated with shorter hospitalization and lower ...
7
Transient cerebral ischemia in an elderly patient with patent foramen ovale and atrial septal aneurysm
... patients, patent foramen ovale (PFO) is seen along with an increased incidence of atrial septal aneurysm ...the foramen ovale following Valsalva’s ...transcatheter closure of the ...
5
Patent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke prevention
... The patent foramen ovale (PFO), given its high prevalence in the general population and especially in patients with cryptogenic stroke, has long generated investigation and debate on its propensity ...
8
Acute Myocardial Infarction in a Child: Possible Pathogenic Role of Patent Foramen Ovale Associated With Heritable Thrombophilia
... Both congenital and acquired coronary artery diseases there- fore were ruled out. Because prothrombin G20210A mutation determines a hypercoagulable state with an increased risk of venous thrombosis and despite the ...
6
Risk and fate of residual interatrial shunting after transcatheter closure of patent foramen ovale: a long term follow up study
... anzola et al. investigated 140 patients undergoing seri- al contrast-enhanced transcranial doppler ofter sucesseful percutaneous PFo-closure. during valsal- va-strain a large shunt was detectable in 9% of pa- ...
7
Case Report Bilateral thalamic infarcts because of the occlusion of the artery of Percheron in a patient with patent foramen ovale: report of a case and review of literature
... suffering from PFO. The PFO disease occurs when a small cardiogenic emboli after blockage causes blood to clot along the arterial wall, thereby resulting in an infarct. PFO is a cardiac septal legacy of tiny abnormal ...
9
Spontaneous Closure of Patent Ductus Arteriosus in Infants ≤1500 g
... and/or patent foramen ovale were excluded, as well as infants with acquired heart disease not related to PDA (such as infectious endocarditis, myocardial infarction, and twin-to- twin transfusion ...
10
Practice advisory: Recurrent stroke with patent foramen ovale (update of practice parameter)Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... PFO closure was seen in 86% of patients who received the ...underwent closure and in ...the closure group and 76% of events in the medical therapy ...underwent closure compared with patients ...
8
Practice Parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm: [RETIRED]Report of the Quality Standards Subcommittee of the American Academy of Neurology*
... Surgical closure was offered to patients with no concomitant stroke etiology and at least two of the following characteris- tics: an ASA, major right-to-left shunt (defined as ⬎ 50 microbubbles on a TTE with a ...
10
Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC Trial): rationale and design
... Methods: The PC-Trial is a randomized clinical trial comparing the efficacy of percutaneous closure of the PFO using the Amplatzer PFO occluder with best medical treatment in patients with cryptogenic embolism, ...
8
Migraineurs with patent foramen ovale have larger right-to-left shunt despite similar atrial septal characteristics
... PFO closure for prevention of recurrent neurovascular events), which make the results of this study difficult to ...probe patent PFO was a criterion for PFO closure, which may have assured a minimum ...
8
AUTONOMIC FUNCTION TEST IN MIGRAINEUR WITH PATENT FORAMEN OVALE
... Consequently, we can speculate the role of PFO in the pathophysiology of migraine trigger. This is supported by significant improvement of migraine symptoms following PFO closure. [9-14] And the higher incidence ...
12
Comparison of Outcomes after Device Closure and Medication Alone in Patients with Patent Foramen Ovale and Cryptogenic Stroke in Korean Population
... the closure group underwent TTE or TEE with agitated saline test to confirm the residual shunt after PFO ...Effective closure was defined as closure with no or minimal shunting, and therefore, was ...
5
High prevalence of patent foramen ovale in migraine with aura
... All patients who underwent PFO closure were treated with ASA. Sporadic episodes of MA, and subsequently no other episodes of MA were recorded in five patients, treat- ed surgically with devices implantation, ...
6
Device closure for patent foramen ovale following cryptogenic stroke: a survey of current practice in the UK
... In this cross-sectional study carried out between 20 December 2014 and 22 February 2015, an online survey was distributed (www. surveymonkey. com) (see online supplementary 1) via the British Cardiac Society, the British ...
5